Cardiovascular disease continues to be the leading cause of death among women in the
United States, accounting for≈ 1 of every 3 female deaths. Sex-specific data focused on …

The first classification on this topic categorized cardiomyopathies as heart muscle diseases
with dilated (DCM), hypertrophic, restrictive, arrhythmogenic right ventricular (ARVC), or …

Major differences between men and women exist in epidemiology, manifestation,
pathophysiology, treatment, and outcome of cardiovascular diseases (CVD), such as …

A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

In the vast majority of cardiovascular diseases (CVDs), there are well-described differences
between women and men in epidemiology, pathophysiology, clinical manifestations, effects …

Background The prevalence of all pregnancies with some form of hypertension can be up to
10%, with the rates of diagnosis varying according to the country and population studied and …

Heparin has been recognized as a valuable anticoagulant and antithrombotic for several
decades and is still widely used in clinical practice for a variety of indications. The …

Aims To describe the outcomes of pregnancy in women with pulmonary hypertension.
Methods and results In 2007 the European Registry on Pregnancy and Heart Disease was …

The incidence of pregnancy in women with cardiovascular disease is rising, primarily due to
the increased number of women with congenital heart disease reaching childbearing age …

Improved medical care of congenital heart disease patients increased survival into
adulthood from 15% in the 1960s to over 85% in the current era. As a consequence, the …